World-first pill may stop Parkinson’s

Hufsamor

Senior Member
Messages
1,221
Likes
4,905
Location
Norway

hixxy

Senior Member
Messages
1,228
Likes
1,411
Location
Australia
The biggest hurdle, apart from funding, is that MCC950 came off a patent. This means the researchers have had to develop variations of the original drug for intellectual property reasons. Those new drugs are currently being tested and, according to Dr Woodruff, proving to be even more effective.
Heaven forbid an unpatented drug be brought to market for the benefit of patients rather than bank accounts. I wonder how many lives this delay developing alternative variations cost?